Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 22, 2016, Pages 6277-6282

  Chen, Edwin ^a   Salinas, Nichole D ^a   Huang, Yining ^a   Ntumngia, Francis ^b   Plasencia, Manolo D ^a   Gross, Michael L ^a   Adams, John H ^b   Tolia, Niraj Harish ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Broadly neutralizing; Duffy Binding Protein; Epitopes; Malaria; Plasmodium vivax

Indexed keywords

DUFFY BINDING PROTEIN; EPITOPE; MALARIA VACCINE; PLASMODIUM VIVAX DUFFY BINDING PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; DUFFY ANTIGEN BINDING PROTEIN, PLASMODIUM; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PARASITE ANTIGEN; PROTEIN BINDING; PROTOZOAL PROTEIN;

ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; DEUTERIUM HYDROGEN EXCHANGE; ENZYME LINKED IMMUNOSORBENT ASSAY; MASS SPECTROMETRY; NONHUMAN; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; X RAY CRYSTALLOGRAPHY; AMINO ACID SEQUENCE; ERYTHROCYTE; GENETIC VARIATION; GENETICS; HUMAN; IMMUNOLOGY; MALARIA, VIVAX; MOLECULAR MODEL; PARASITOLOGY; PATHOLOGY; PROTEIN CONFORMATION;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIGENS, PROTOZOAN; CRYSTALLOGRAPHY, X-RAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, B-LYMPHOCYTE; ERYTHROCYTES; GENETIC VARIATION; HUMANS; MALARIA VACCINES; MALARIA, VIVAX; MODELS, MOLECULAR; PLASMODIUM VIVAX; PROTEIN BINDING; PROTEIN CONFORMATION; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE;

EID: 84971571508     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1600488113     Document Type: Article

References (64)

1. Carlton JM, Sina BJ, Adams JH (2011) Why is Plasmodium vivax a neglected tropical disease? PLoS Negl Trop Dis 5(6):e1160.
2. Tjitra E, et al. (2008) Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia. PLoS Med 5(6):e128.
3. Genton B, et al. (2008) Plasmodium vivax and mixed infections are associated with severe malaria in children: A prospective cohort study from Papua New Guinea. PLoS Med 5(6):e127.
4. Guerra CA, et al. (2010) The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 4(8):e774.
5. Price RN, et al. (2007) Vivax malaria: Neglected and not benign. Am J Trop Med Hyg 77(6, Suppl):9-87.
6. King CL, et al. (2008) Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci USA 105(24):8363-8368.
7. Grimberg BT, et al. (2007) Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med 4(12):e337.
8. Ntumngia FB, et al. (2014) Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II. Clin Vaccine Immunol 21(9):1215-1223.
9. Chootong P, et al. (2010) Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. Infect Immun 78(3):1089-1095.
10. Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK (1975) Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189(4202):561-563.
11. Miller LH, Mason SJ, Clyde DF, McGinniss MH (1976) The resistance factor to Plasmodium vivax in blacks: The Duffy-blood-group genotype, FyFy. N Engl J Med 295(6):302-304.
12. Wertheimer SP, Barnwell JW (1989) Plasmodium vivax interaction with the human Duffy blood group glycoprotein: Identification of a parasite receptor-like protein. Exp Parasitol 69(4):340-350.
13. Adams JH, et al. (1990) The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell 63(1):141-153.
14. Adams JH, et al. (1992) A family of erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci USA 89(15):7085-7089.
15. Chitnis CE, Chaudhuri A, Horuk R, Pogo AO, Miller LH (1996) The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J Exp Med 184(4):1531-1536.
16. Ranjan A, Chitnis CE (1999) Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocytebinding proteins. Proc Natl Acad Sci USA 96(24):14067-14072.
17. VanBuskirk KM, Sevova E, Adams JH (2004) Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc Natl Acad Sci USA 101(44):15754-15759.
18. Batchelor JD, Zahm JA, Tolia NH (2011) Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat Struct Mol Biol 18(8):908-914.
19. Batchelor JD, et al. (2014) Red blood cell invasion by Plasmodium vivax: Structural basis for DBP engagement of DARC. PLoS Pathog 10(1):e1003869.
20. Salinas ND, Tolia NH (2016) Red cell receptors as access points for malaria infection. Curr Opin Hematol 23(3):215-223.
21. Malpede BM, Tolia NH (2014) Malaria adhesins: Structure and function. Cell Microbiol 16(5):621-631.
22. Paing MM, Tolia NH (2014) Multimeric assembly of host-pathogen adhesion complexes involved in apicomplexan invasion. PLoS Pathog 10(6):e1004120.
23. Tolia NH, Enemark EJ, Sim BK, Joshua-Tor L (2005) Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 122(2):183-193.
24. Salinas ND, Tolia NH (2014) A quantitative assay for binding and inhibition of Plasmodium falciparum Erythrocyte Binding Antigen 175 reveals high affinity binding depends on both DBL domains. Protein Expr Purif 95:188-194.
25. Salinas ND, Paing MM, Tolia NH (2014) Critical glycosylated residues in exon three of erythrocyte glycophorin A engage Plasmodium falciparum EBA-175 and define receptor specificity. MBio 5(5):e01606-e01614.
26. Sim BK, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH (1994) Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 264(5167):1941-1944.
27. Malpede BM, Lin DH, Tolia NH (2013) Molecular basis for sialic acid-dependent receptor recognition by the Plasmodium falciparum invasion protein erythrocytebinding antigen-140/BAEBL. J Biol Chem 288(17):12406-12415.
28. Lin DH, Malpede BM, Batchelor JD, Tolia NH (2012) Crystal and solution structures of Plasmodium falciparum erythrocyte-binding antigen 140 reveal determinants of receptor specificity during erythrocyte invasion. J Biol Chem 287(44):36830-36836.
29. Ménard D, et al. (2010) Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci USA 107(13):5967-5971.
30. Menard D, et al. (2013) Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains. PLoS Negl Trop Dis 7(11):e2489.
31. Chen E, Paing MM, Salinas N, Sim BK, Tolia NH (2013) Structural and functional basis for inhibition of erythrocyte invasion by antibodies that target Plasmodium falciparum EBA-175. PLoS Pathog 9(5):e1003390.
32. Ntumngia FB, et al. (2012) Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies. Infect Immun 80(3):1203-1208.
33. Cole-Tobian JL, et al. (2009) Strain-specific Duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous Plasmodium vivax strains in Papua New Guinean children. Infect Immun 77(9):4009-4017.
34. VanBuskirk KM, et al. (2004) Antigenic drift in the ligand domain of Plasmodium vivax Duffy binding protein confers resistance to inhibitory antibodies. J Infect Dis 190(9):1556-1562.
35. Nóbrega De Sousa T, Carvalho LH, Alves De Brito CF (2011) Worldwide genetic variability of the Duffy binding protein: Insights into Plasmodium vivax vaccine development. PLoS One 6(8):e22944.
36. Ceravolo IP, et al. (2009) Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection. Clin Exp Immunol 156(3):502-510.
37. Ntumngia FB, et al. (2013) Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II. Vaccine 31(40):4382-4388.
38. Chen E, Salinas ND, Ntumngia FB, Adams JH, Tolia NH (2015) Structural analysis of the synthetic Duffy Binding Protein (DBP) antigen DEKnull relevant for Plasmodium vivax malaria vaccine design. PLoS Negl Trop Dis 9(3):e0003644.
39. Zhou T, et al.; NISC Comparative Sequencing Program (2015) Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors. Cell 161(6):1280-1292.
40. Ekiert DC, Wilson IA (2012) Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. Curr Opin Virol 2(2):134-141.
41. Dormitzer PR, Grandi G, Rappuoli R (2012) Structural vaccinology starts to deliver. Nat Rev Microbiol 10(12):807-813.
42. Lawrence MC, Colman PM (1993) Shape complementarity at protein/protein interfaces. J Mol Biol 234(4):946-950.
43. Petoukhov MV, Svergun DI (2005) Global rigid body modeling of macromolecular complexes against small-angle scattering data. Biophys J 89(2):1237-1250.
44. Fischer H, De Oliveira Neto M, Napolitano HB, Polikarpov I, Craievich AF (2010) Determination of the molecular weight of proteins in solution from a single small-angle X-ray scattering measurement on a relative scale. J Appl Cryst 43(1):101-109.
45. Hura GL, et al. (2013) Comprehensive macromolecular conformations mapped by quantitative SAXS analyses. Nat Methods 10(6):453-454.
46. Haste Andersen P, Nielsen M, Lund O (2006) Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci 15(11):2558-2567.
47. Ntumngia FB, Adams JH (2012) Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax Duffy binding protein. Clin Vaccine Immunol 19(1):30-36.
48. Cole-Tobian J, King CL (2003) Diversity and natural selection in Plasmodium vivax Duffy binding protein gene. Mol Biochem Parasitol 127(2):121-132.
49. Baum J, Thomas AW, Conway DJ (2003) Evidence for diversifying selection on erythrocyte-binding antigens of Plasmodium falciparum and P. vivax. Genetics 163(4):1327-1336.
50. Welsh RM, Fujinami RS (2007) Pathogenic epitopes, heterologous immunity and vaccine design. Nat Rev Microbiol 5(7):555-563.
51. Tournamille C, et al. (1997) Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding. J Biol Chem 272(26):16274-16280.
52. Aricescu AR, Lu W, Jones EY (2006) A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D Biol Crystallogr 62(Pt 10):1243-1250.
53. Kabsch W (2010) XDS. Acta Crystallogr D Biol Crystallogr 66(Pt 2):125-132.
54. McCoy AJ, et al. (2007) Phaser crystallographic software. J Appl Cryst 40(Pt 4):658-674.
55. Marcatili P, Rosi A, Tramontano A (2008) PIGS: Automatic prediction of antibody structures. Bioinformatics 24(17):1953-1954.
56. Adams PD, et al. (2002) PHENIX: Building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58(Pt 11):1948-1954.
57. Schröder GF, Levitt M, Brunger AT (2010) Super-resolution biomolecular crystallography with low-resolution data. Nature 464(7292):1218-1222.
58. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60(Pt 12 Pt 1):2126-2132.
59. Davis IW, et al. (2007) MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35 (Web Server Issue):W375-W383.
60. Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372(3):774-797.
61. Morin A, et al. (2013) Collaboration gets the most out of software. eLife 2:e01456.
62. Hura GL, et al. (2009) Robust, high-throughput solution structural analyses by small angle X-ray scattering (SAXS). Nat Methods 6(8):606-612.
63. Petoukhov MV, et al. (2012) New developments in the ATSAS program package for small-angle scattering data analysis. J Appl Cryst 45(Pt 2):342-350.
64. Yan Y, Grant GA, Gross ML (2015) Hydrogen-deuterium exchange mass spectrometry reveals unique conformational and chemical transformations occurring upon [4Fe-4S] cluster binding in the type 2 L-serine dehydratase from Legionella pneumophila. Biochemistry 54(34):5322-5328.